» Articles » PMID: 26453406

The Classification of Osteonecrosis in Patients with Cancer: Validation of a New Radiological Classification System

Overview
Journal Clin Radiol
Specialty Radiology
Date 2015 Oct 11
PMID 26453406
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To validate a new, non-joint-specific radiological classification system that is suitable regardless of the site of the osteonecrosis (ON) in patients with cancer.

Material And Methods: Critical deficiencies in the existing ON classification systems were identified and a new, non-joint-specific radiological classification system was developed. Seventy-two magnetic resonance imaging (MRI) images of patients with cancer and ON lesions were graded, and the validation of the new system was performed by assessing inter- and intra-observer reliability.

Results: Intra-observer reliability of ON grading was good or very good, with kappa values of 0.79-0.86. Interobserver agreement was lower but still good, with kappa values of 0.62-0.77. Ninety-eight percent of all intra- or interobserver differences were within one grade. Interobserver reliability of assessing the location of ON was very good, with kappa values of 0.93-0.98.

Conclusion: All the available radiological ON classification systems are joint specific. This limitation has spurred the development of multiple systems, which has led to the insufficient use of classifications in ON studies among patients with cancer. The introduced radiological classification system overcomes the problem of joint-specificity, was found to be reliable, and can be used to classify all ON lesions regardless of the affected site.

Citing Articles

Bone health in childhood cancer survivors, is there really a problem? Pitfalls of assessment, calculating risk, and suggested surveillance and management for osteonecrosis and low and very low bone mineral density.

de Winter D, Neggers S, van den Heuvel-Eibrink M, van Atteveld J Endocr Connect. 2024; 13(12).

PMID: 39437150 PMC: 11623254. DOI: 10.1530/EC-24-0487.


Physical impairments, activity limitations, and participation restrictions of childhood acute lymphoblastic leukemia survivors with and without hip osteonecrosis: a PETALE cohort study.

Brochu A, Kairy D, Alos N, Laverdiere C, Sinnett D, Sultan S J Cancer Surviv. 2024; .

PMID: 38787491 DOI: 10.1007/s11764-024-01585-4.


[Osteonecrosis-severe side effect of treatment for acute lymphoblastic leukemia].

Kuhlen M, Kunstreich M, Gokbuget N, Escherich G Orthopadie (Heidelb). 2022; 51(10):792-799.

PMID: 36069910 DOI: 10.1007/s00132-022-04301-1.


Osteonecrosis in paediatric acute lymphoblastic leukaemia: Incidence, risk factors, radiological patterns and evolution in a single-centre cohort.

Brivio E, Cossio A, Borra D, Silvestri D, Prunotto G, Colombini A Br J Haematol. 2022; 197(5):602-608.

PMID: 35362095 PMC: 9323502. DOI: 10.1111/bjh.18147.


Recent perspectives on the association between osteonecrosis and bone mineral density decline in childhood acute lymphoblastic leukemia.

van Atteveld J, de Winter D, Pieters R, Neggers S, van den Heuvel-Eibrink M Fac Rev. 2021; 10:57.

PMID: 34308423 PMC: 8265561. DOI: 10.12703/r/10-57.